An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
Hepatology2016Vol. 65(4), pp. 1196–1205
Citations Over TimeTop 10% of 2016 papers
Omair Atiq, Jasmin A. Tiro, Adam C. Yopp, Adam Muffler, Jorge A. Marrero, Neehar D. Parikh, Caitlin C. Murphy, Katharine McCallister, Amit G. Singal
Abstract
Over one fourth of patients with cirrhosis experience physical harm for false-positive or indeterminate surveillance tests-more often related to ultrasound than AFP. Interventions are needed to reduce surveillance-related harm to increase the value of HCC screening programs in clinical practice. (Hepatology 2017;65:1196-1205).
Related Papers
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- → Hepatology and Transplant Hepatology(2010)2 cited
- Application of Diffusion Weighted Imaging in Liver Cirrhosis and Hepatocellular Carcinoma at 3.0 T Magnetic Resonance(2008)
- [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].(1990)
- → P0320 AUTOIMMUNE HEPATITIS: MULTICENTRE DATA AT DIAGNOSIS IN 245 CHILDREN(2004)